GREEN LIFESCIENCE CO. LTD.
KKRX:1144502,180.00
KRW
+35.00
(+1.63%)
ISIN
KR7114450000
Return %
Stock
S&P 500
1Y
-9.73
14.39
3Y
15.96
81.42
5Y
-61.19
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- Full Time Employees
- 65
- Sector
- Process industries
- Industry
- Chemicals: major diversified
- Address
- Yeosu-si South Korea
- IPO Date
- Dec 22, 2009
- Website
- korgl.com
- Similar Companies
- Business
- Green LifeScience Co., Ltd. is a South Korea-based fine chemical and life sciences company that specializes in the research, development, custom synthesis, and manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, agrochemical raw materials, and advanced electronic materials. Founded in 2005 and headquartered in Yeosu, South Korea, the company operates cGMP-compliant synthesis facilities and supplies high-purity chemical compounds to domestic and multinational pharmaceutical, agricultural, and industrial markets. The company's core product and service offerings comprise: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates, including piperacillin-based antibiotic intermediates such as EDP-CL and AM19; N,N'-disuccinimidyl carbonate (DSIC) utilized in the synthesis of antiretroviral HIV treatments; 1,1'-carbonyldiimidazole (CDI) coupling reagents; Amoxapine antidepressant raw materials; and intermediate compounds for cardiovascular, oncological, and antimicrobial formulations; Agrochemical Raw Materials and Intermediates, including AMZ, CCIM, and IKF-309 compounds formulated for crop protection, fungicides, and pesticide manufacturing; Advanced Specialty and Electronic Materials, encompassing high-purity chemical compounds and process materials developed for semiconductor and AI hardware manufacturing applications; and Custom Synthesis and Contract Manufacturing Services, delivering multi-step chemical synthesis, process optimization, phosgenation, hydrogenation, and peptide chemistry solutions. Geographically, the company distributes its products domestically and exports to global markets, including the United States, Japan, and Brazil. In recent corporate developments, the company, formerly known as KPX Life Science Co., Ltd., completed a corporate name change to Green LifeScience Co., Ltd. to align with its expanded strategic scope. Demonstrating strategic diversification beyond life sciences, the company entered the advanced technology supply chain by securing major supply agreements for AI semiconductor materials with Green Chemical Co., Ltd. In addition, Green LifeScience expanded its international agrochemical business through substantial supply contracts for plant health and crop protection chemicals with global agricultural partners such as UPL Limited targeting the Brazilian market, while advancing new capital facility investments and adjustments to its major shareholding structure to support production scalability.